Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China: a real-world assessment

被引：1
|
作者：
Peng, Yongquan [1 ]
Cao, Xujian [1 ]
Wang, Yating [1 ]
Yu, Weiwei [2 ]
Zeng, Ziwei [2 ]
Wang, Min [2 ]
机构：
[1] Univ South China, Hosp Changsha 1, Grad Collaborat Training Base, Grad Collaborat Training Base, Hengyang 421001, Hunan, Peoples R China
[2] First Hosp Changsha, Inst HIV AIDS, Changsha 410000, Hunan, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2023年 / 136卷 / 22期
关键词：
D O I：
10.1097/CM9.0000000000002888
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2738 / 2740
页数：3
相关论文
共 50 条
  • [1] Outcomes of bictegravir/emtricitabine/tenofovir alafenamide versus efavirenz-based regimens in central China: a real-world assessment
    Peng Yongquan
    Cao Xujian
    Wang Yating
    Yu Weiwei
    Zeng Ziwei
    Wang Min
    中华医学杂志英文版, 2023, 136 (22)
  • [2] Real-world persistence with dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir-alafenamide among persons with HIV
    Martin-Zaragoza, Lorena
    Sanchez-Rubio-Ferrandez, Javier
    Onteniente-Gonzalez, Alberto
    Gomez-Bermejo, Marcos
    Rodriguez-Alvarez, Sergio Julio
    Monereo-Alonso, Alfonso
    Molina-Garcia, Teresa
    FARMACIA HOSPITALARIA, 2024, 48 (04) : T171 - T175
  • [3] Switching to Dolutegravir/lamivudine or Bictegravir/Emtricitabine/Tenofovir alafenamide. A comparative real-world study
    Knobel, Hernando
    Canas-Ruano, Esperanza
    Guelar, Ana
    Knobel, Pablo
    Villar-Garcia, Judit
    Gonzalez-Mena, Alicia
    Canepa, Ceclia
    Arrieta-Aldea, Itziar
    Marcos, Augustin
    Abalat-Torrres, Agusti
    Gerri-Fernandez, Roberto
    HIV RESEARCH & CLINICAL PRACTICE, 2023, 24 (01)
  • [4] Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/Emtricitabine/Tenofovir Alafenamide
    Maggiolo, Franco
    Valenti, Daniela
    Teocchi, Rodolfo
    Comi, Laura
    Di Filippo, Elisa
    Rizzi, Marco
    JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2022, 21
  • [5] Efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide for the treatment of HIV in a real-world setting in Belgium
    Nasreddine, Rakan
    Florence, Eric
    Yombi, Jean Cyr
    Henrard, Sophie
    Darcis, Gilles
    Van Praet, Jens
    Vandekerckhove, Linos D.
    Allard, Sabine
    Demeester, Remy
    Messiaen, Peter
    Ausselet, Nathalie
    Delforge, Marc
    De Wit, Stephane
    HIV MEDICINE, 2023, 24 (08) : 914 - 924
  • [6] Real-world efficacy and safety of switching to bictegravir/emtricitabine/tenofovir alafenamide in older people living with HIV
    Rolle, Charlotte-Paige
    Nguyen, Vu
    Patel, Kiran
    Cruz, Dan
    DeJesus, Edwin
    Hinestrosa, Federico
    MEDICINE, 2021, 100 (38)
  • [7] Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
    Emond, Bruno
    Rossi, Carmine
    Cote-Sergent, Aurelie
    Dunn, Keith
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Donga, Prina
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 88 - 98
  • [8] Real-world efficacy of switching to bictegravir/ emtricitabine/tenofovir alafenamide in pretreated patients with triple therapy containing rilpivirine
    de Gea Grela, Alejandro
    Martin Carbonero, Luz
    Mican, Rafael
    Ignacio Bernardino, Jose
    Ramos, Luis
    Eulalia Valencia, Ma
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 (04) : 378 - 381
  • [9] Real-world effects of treatment with emtricitabine/tenofovir alafenamide- versus emtricitabine/tenofovir disoproxil fumarate-based regimens in people living with HIV in a clinical cohort in Germany
    Rieke, A.
    Jessen, H.
    Pauli, R.
    Waizmann, M.
    Heuchel, T.
    Postel, N.
    Lymperopoulou, C.
    Faghmous, I.
    Diaz-Cuervo, H.
    Ramroth, H.
    Stellbrink, H.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [10] Coformulated Bictegravir/Emtricitabine/Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Assault: A Retrospective Real-World Study
    de Jesus, Cabrera-Lopez Teresita
    Edgar, Perez-Barragan
    Ruben, Nava-Campos Carlos
    Marla, Toiber-Rodriguez
    Carlos, Rodriguez-Aldama Juan
    Adrian, Cruz-Flores Raul
    Andrea, Gonzalez-Rodriguez
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (08):
12345